Rachel Klemovitch, Assistant Editor02.13.24
Trelleborg Group has signed an agreement to acquire Baron Group, a prominent Australian-Chinese company in manufacturing advanced precision silicone components. The acquisition was made through the Trelleborg Sealing Solutions business area and will strengthen the Group’s application expertise and manufacturing capacity.
The Baron Group is a privately held company with its head office and two manufacturing facilities in Australia. Baron Group also has two facilities in China.
This also positions the Group as a global partner for medical technology products such as sleep apnea, respiratory care, and chronic obstructive pulmonary disease (COPD).
This acquisition strengthens Trelleborg’s presence in Asia and Australia and allows the Group to meet customer needs for global partnerships while leveraging growth in Asia Pacific and North America.
It also provides expanded manufacturing capacity for injection molding for silicone and plastics, as well as increased manufacturing capacity for liquid silicone rubber (LSR).
In 2023 Baron Group generated approximately $1,000 million in sales with a margin in line with the Trelleborg Sealing Solutions business area.
“The acquisition of Baron Group marks a significant milestone in our ambition to build a comprehensive and complete healthcare & medical offering. The company's complementary culture and similar working methods make Baron Group an excellent addition to Trelleborg's existing offerings. We are convinced that this partnership will generate significant sales and production synergies,” said Peter Nilsson, President and CEO of Trelleborg Group.
Trelleborg Sealing Solutions business area president, Peter Hahn commented, “Baron Group and Trelleborg share a common vision when it comes to offering outstanding customer service, from prototyping to serial production. Together with Baron, we will not only strengthen our production capacity and application expertise in complex precision components but also benefit from its outstanding tool-making and material laboratory.”
The purchase price is $300 million on a cash and debt-free basis. The transaction is expected to be finalized in the first half of 2024.
The Baron Group is a privately held company with its head office and two manufacturing facilities in Australia. Baron Group also has two facilities in China.
This also positions the Group as a global partner for medical technology products such as sleep apnea, respiratory care, and chronic obstructive pulmonary disease (COPD).
This acquisition strengthens Trelleborg’s presence in Asia and Australia and allows the Group to meet customer needs for global partnerships while leveraging growth in Asia Pacific and North America.
It also provides expanded manufacturing capacity for injection molding for silicone and plastics, as well as increased manufacturing capacity for liquid silicone rubber (LSR).
In 2023 Baron Group generated approximately $1,000 million in sales with a margin in line with the Trelleborg Sealing Solutions business area.
“The acquisition of Baron Group marks a significant milestone in our ambition to build a comprehensive and complete healthcare & medical offering. The company's complementary culture and similar working methods make Baron Group an excellent addition to Trelleborg's existing offerings. We are convinced that this partnership will generate significant sales and production synergies,” said Peter Nilsson, President and CEO of Trelleborg Group.
Trelleborg Sealing Solutions business area president, Peter Hahn commented, “Baron Group and Trelleborg share a common vision when it comes to offering outstanding customer service, from prototyping to serial production. Together with Baron, we will not only strengthen our production capacity and application expertise in complex precision components but also benefit from its outstanding tool-making and material laboratory.”
The purchase price is $300 million on a cash and debt-free basis. The transaction is expected to be finalized in the first half of 2024.